Tokyo bourse overhaul spurs prime market push for Japanese firms
Tighter requirements to stay on the Tokyo bourse’s prestigious main board are forcing Japanese companies to cease long criticised…
Key Words: ‘It’s not a month to be a hero,’ warns stock-market strategist Tom Lee, after Dow logs worst day of 2021
Thomas Lee, founder of Fundstrat Global Advisors, has a word of advice for investors hoping to buy the dip after Monday’s selloff….
Rising Covid cases spark fears of resurgent pandemic in US
Biden implores Americans to get vaccinated and stocks fall amid outbreaks in areas with low inoculation ratesA rapid increase…
IBM revenue grows for second straight quarter, cheering investors
IBM Corp. provided the best evidence yet today that it’s back on a growth track, reporting second-quarter revenue rose 3% from…
Stocks skid as virus fears shake markets; Dow falls 2.1%
NEW YORK (AP) — Resurgent pandemic worries knocked stocks lower from Wall Street to Tokyo on Monday, fueled by fears that a faster-spreading…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against RenovaCare, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES–(BUSINESS WIRE)—- $RCAR #RCAR–SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action…
Clover Leaf Capital Corp. Announces Pricing of $125.0 Million Initial Public Offering
Miami, FL., July 19, 2021 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (Nasdaq: CLOEU) (“Clover Leaf” or the “Company”) today…
Is Immatics N.V. (IMTX) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund…
Hedge Funds Are Buying Super Micro Computer, Inc. (SMCI)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of…
Hedge Funds Are Crazy About Aptose Biosciences Inc (APTO)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance,…